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Bone marrow–derived mesenchymal stem cells (MSCs) differentiate into osteoblasts upon stimulation by signals present in
their niche. Because the global signaling cascades involved in the early phases of MSCs osteoblast (OB) differentiation are
not well-defined, we used quantitative mass spectrometry to delineate changes in human MSCs proteome and phosphopro-
teome during the first 24 h of their OB lineage commitment. The temporal profiles of 6252 proteins and 15,059 phosphor-
ylation sites suggested at least two distinct signaling waves: one peaking within 30 to 60 min after stimulation and a second
upsurge after 24 h. In addition to providing a comprehensive view of the proteome and phosphoproteome dynamics during
early MSCs differentiation, our analyses identified a key role of serine/threonine protein kinase D1 (PRKD1) in OB commit-
ment. At the onset of OB differentiation, PRKD1 initiates activation of the pro-osteogenic transcription factor RUNX2 by
triggering phosphorylation and nuclear exclusion of the histone deacetylase HDAC7.
[Supplemental material is available for this article.]
The skeleton is a dynamic tissue constantly undergoing bone ma-
trix resorption and formation, two coupled processes mediated by
osteoclastic and osteoblastic cells, respectively (Parfitt et al. 2011).
Decreased osteoblastic bone formation relative to osteoclastic
bone resorption is the cellular basis of age- and osteoporosis-relat-
ed bone loss (Feng and McDonald 2011). Osteoblasts differentiate
from skeletal stem cells, also known as stromal or mesenchymal
stem cells (MSCs), which are present within the bone marrow
stroma. MSCs are among the most suitable cell types for cell
therapy applications due to their ease of isolation, multilineage
differentiation potential, their immunomodulatory and regenera-
tion promoting properties, as well as their excellent safety record
(Jafari et al. 2014; Zaher et al. 2014). Therefore, MSCs have been
used in an increasing number of clinical trials for enhancing tissue
repair in different contexts such as regeneration of skeletal defects
(Andrzejewska et al. 2019). Determining the signaling mecha-
nisms that regulate MSCs commitment and differentiation into
the bone-forming osteoblastic cells can pave way for the develop-
ment of novel approaches for enhancing bone formation and
treating osteoporotic bone loss (Abdallah et al. 2015).
The current model of osteoblast (OB) differentiation from
stemcells is based on a large number of in vitro studies and consists
of a progressive differentiation sequence that includes phases of
cell proliferation followed by cell maturation, extracellular matrix
production and, lastly, matrix mineralization (Lian and Stein
1995). Although this model is useful as an overview, there is a
need for delineating the molecular and signaling events underly-
ing these phases. Several previous studies have used a reduction-
ist approach to determine factors and signaling pathways that
are important for OB differentiation and identified a number of
key signaling cascades including Wnt, Hedgehog, Notch, and
Bone morphogenetic proteins (BMPs) (Abdallah et al. 2015; Hojo
et al. 2015). However, such approaches fail to provide information
regarding how signaling events are initiated and integrated in a co-
herent, well-orchestrated biological process.
Over the last decade, mass spectrometry (MS)-based proteo-
mics has evolved as a powerful platform for studying complex bi-
ological processes at a systemwide level. We and others have
previously used MS-based quantitative proteomics using stable
isotope labeling by amino acids in cell culture (SILAC) to provide
a global overview of human embryonic stem cell proteomes
and phosphoproteomes during differentiation (Prokhorova et al.
2009; Van Hoof et al. 2009; Rigbolt et al. 2011a; Rigbolt and
Blagoev 2012), to monitor receptor tyrosine kinase signaling
in MSCs differentiation to osteoblasts (Kratchmarova et al.
2005), and to determine secreted factors during OB differentiation
(Kristensen et al. 2012), as well as proteome and secretome varia-
tions during muscle cell differentiation (Henningsen et al. 2010;
Le Bihan et al. 2015). Here, we combined SILAC-based quantitative
proteomic and phosphoproteomic analyses to elucidate the signal-
ing events occurring during the first 24 h of OB differentiation of
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human MSCs, identifying more than 6000 proteins and 15,000
phosphorylation sites.
Results
Temporal profiling of the proteome and phosphoproteome
during hMSC commitment to osteoblastic lineage
SILAC-labeled hMSCs were either left unstimulated or induced to
undergo OB differentiation for 30 min, 1, 6, or 24 h (Fig. 1A).
Cell lysates were separated into nuclear and cytoplasmic fractions
and each combined into two different SILAC pools allowing com-
parable quantitation of proteins and phosphorylation events at
the five time points. Cell lysates were either subjected to 1D gel
electrophoresis followed by in-gel digestion for proteome determi-
nation or to enrichment of phosphopeptides before LC-MS/MS
measurements for delineation of phosphorylation events at a
site-specific level (Fig. 1A).
We identified 6252 proteins (Supplemental Table S1), of
which 565 showed changes in at least one time point (P<0.05
with at least 1.5-fold increase or decrease). Thenumberof regulated
proteins increased from an average of 250 proteins during the first
6 h to nearly 350 at 24 h (Fig. 1B). The phosphoproteomic analysis
identified 15,059 unique phosphorylation siteswith an overall dis-
tribution of 88% on serine, 10% on threonine, and 2% on tyrosine
residues (Supplemental Table S2). Quantitative information was
obtained for10,930 sites, ofwhich797displayedsignificant chang-
es in abundance in at least one time point (P<0.05 with at least
twofold increase or decrease compared to unstimulated cells). In
contrast to the observed changes in protein abundances, the high-
est number of altered phosphorylation sites was observed shortly
after induction of differentiation, followed by a drop at 6 h, before
a secondary boost at 24 h, hinting to the presence of two signaling
waves during early OB differentiation (Fig. 1B).
The proteomic landscape changed within the 24 h after induction
of OB differentiation
To examine the dynamics of protein expression at a global level,
we used unsupervised fuzzy c-means clustering (Supplemental
Fig. S1A). Because the majority of the protein alterations occurred
at later time points, we focused on the data from the 6- and 24-h
time points. Proteins grouped into six clusters with a general
down-regulation (Clusters 1 and 3), up-regulation (Clusters 2
and 6), or transient changes (Clusters 4 and 5) (Supplemental
Fig. S1A). Analyses using Gene Ontology (GO) (Ashburner et al.
2000) revealed enrichment for several biological processes andmo-
lecular functions in each individual cluster (Supplemental Fig.
S1B,C).We found enrichment in different processes related to “ex-
tracellular matrix” in Clusters 1 and 2 that represent early respon-
sive proteins. Proteins related to “collagen metabolism” and
“extracellular matrix disassembly” were found in Cluster 1
(down-regulated at 6 h and 24 h after induction), whereas proteins
associated with “extracellular matrix organization” were found in
Cluster 2 (up-regulated 6 h and 24 h after the induction). Proteins
involved in “DNA replication and regulation of cell proliferation”
were also enriched in Cluster 2, suggesting that the initial phase of
MSC osteoblast differentiation is associated with enhanced cell
division, which is in accordance with previous findings (Lian
and Stein 1995; Marumoto et al. 2017).
Some of the regulated proteins showed significant changes
only 24 h after the onset of differentiation (Cluster 6). Several of
the proteins in this cluster were associated with the transforming
growth factor beta (TGFB) and Hippo pathways indicating in-
creased contribution of these signaling networks in the differenti-
ation process at this later time point. A significant fraction of the
proteins underwent only a temporal change in their expression
(Clusters 4 and 5). Proteins linked with Toll-like receptor signaling
were overrepresented in Cluster 4, characterized by a transient
decrease, whereas proteins involved in “transcriptional regula-
tion” were enriched in the group with temporary elevated levels
(Cluster 5).
Because transcription factors play pivotal roles in cellular dif-
ferentiation responses, we extracted and quantified transcription
factors present within the identified protein clusters. We found
140 transcription factors with DNA-binding motifs according to
their GO terms (Fig. 2), of which 32 showed temporal changes.
Among these, 22 were regulated at either protein or phosphosite
level and were linked with terms related to cell differentiation,
bone mineral density, and ossification (Supplemental Fig. S2). For
example,CCAATenhancer bindingproteinbeta (CEBPB) anddelta
(CEBPD),whicharemembers of thebasic leucinezipper (bZIP) fam-
ily, were up-regulated at the 6- and 24-h time points. The two tran-
scription factors are known to interact and positively regulate
B
A
Figure 1. Quantitativemass spectrometry revealed widespread changes
during the initial period of osteoblast commitment. (A) Flow diagram of
the quantitative proteomic and phosphoproteomic experiment. Human
MSCs were labeled with the indicated combinations of arginine (Arg)
and lysine (Lys) SILAC amino acids, induced to undergo osteoblast differ-
entiation, and harvested at indicated time points. After cell lysis and frac-
tionation, proteins were pooled, digested, and either analyzed by LC-
MS/MS or enriched for phosphorylated species followed by LC-MS/MS
analysis. (B) Numbers of significantly changed phosphorylation sites
(left) and proteins (right) at indicated time points during osteoblastogene-
sis relative to undifferentiated cells.
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RUNX family transcription factor 2 (RUNX2)-mediated gene ex-
pression (Gutierrez et al. 2002). Fork-head transcription factors
were in general down-regulated with the exception of FOXO3,
which was slightly up-regulated at 6 and 24 h in agreement with
a role of this factor in protecting osteoblasts from oxidative stress
andapoptosis (Ambrogini et al. 2010). Furthermore, the zinc-finger
proteins ZFP36L1 and ZFP36L2 were also found increased at the
protein level (Fig. 2). These two factors are known to be up-regulat-
ed in response to several extracellular signals such as TGFB, TNFA,
EGF, and glucocorticoids. Both have been reported to play impor-
tant roles in cell differentiation (Stumpo et al. 2009; Chen et al.
2015; Tseng et al. 2017) and, for ZFP36L1, to favor OB differentia-
tion over adipogenesis (Tseng et al. 2017).
Changes in the phosphoproteome revealed two intracellular
kinase-signaling waves associated with OB lineage commitment
of hMSC
Various members frommost of the kinase families were represent-
ed in our data set, covering 187 quantified kinases: 30 were altered
at the protein level, and 45 showed changes in their phosphoryla-
tion status (Fig. 3). To assess the importance of the identified fluc-
tuations, we selected 10 kinases hitherto not associated with
osteoblast differentiation and examined the effect of their individ-
ual knockdown on the conversion of hMSCs into osteoblasts. Of
these kinases, eight were regulated at their level of expression
and two at their phosphorylation status. Knockdown of seven of
the 10 candidates had a significant impact on alkaline phospha-
tase activity at day 6 of differentiation (Fig. 4). Moreover, silencing
of the kinases identified as possible negative regulators by quanti-
tative proteomics, that is, down-regulated in theMS data set, led to
stimulation of osteoblast conversion, whereas knockdown of the
potential positive regulators resulted in reduced differentiation.
We next extracted overrepresented linear phosphorylation
motifs from the identified phosphorylation sites and possible ki-
nases capable of phosphorylating these motifs (Fig. 5A, left). The
predictions were then correlated with the quantified dynamics
of the corresponding phosphorylation sites (Fig. 5A, right). This
depiction allows identification of kinases affiliated with highly
regulated motifs and their dynamic changes during OB differenti-
ation. The prediction identified the mitogen-activated protein ki-
nase 14 (MAPK14, also known as p38) as a putative kinase for
many of the regulated sites (Fig. 5A) and indeed MAPK14 is an im-
portant known regulator ofOB differentiation (Rodríguez-Carballo
et al. 2016). However, otherMAPKmembers could not be excluded
as possible candidates because the phosphorylationmotif is shared
among them. We identified activating phosphorylation sites on
two of these kinases, MAPK3 and MAPK1 (also known as ERK1
and ERK2, respectively), both peaking at 30 min (Supplemental
Table S2). Phosphorylation of MAPK14 itself was not detected in
Figure 2. The levels of several transcription factors are altered during early osteoblast commitment. Identified and quantified transcription factors were
ordered by the phylogenetic distance of their DNA-binding domains and aligned using iTOL (Letunic and Bork 2019). Histogram in the outer ring repre-
sents the regulation at protein level during induction of osteoblastic differentiation. Color codes for the different families are shown on the right.
Signaling waves during hMSCs osteoblast commitment
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the MS analyses, but western blot analysis revealed that, in con-
trast to ERKs, MAPK14 maintained high levels of activation even
at 1 h (Supplemental Fig. S3A).
To obtain further insights into the involvement ofMAPKs, we
extracted the 1287 predicted phosphorylation sites for the MAPK
family present in our data set, clustered themaccording to their dy-
namic changes, and assessed for overrepresented biological pro-
cesses in the corresponding clusters (Supplemental Fig. S3B,C).
We observed that sites correlating with the dynamics of MAPK14
activation, that is, with increased phosphorylation at the first
two time points after stimulation and peaking at 1 h (Cluster 3),
were enriched in categories associated with OB lineage commit-
ment, for example, “osteoblast development” and “positive regu-
lation of osteoblast differentiation.” This was not the case for
proteins belonging to clusters that resemble the activation profile
of the ERKs with its maximum effect after 30min. This argues that
despite several of the MAPK family members were activated,
MAPK14was crucial inmediating the early steps in OB conversion
of hMSCs. In this Cluster 3, we also identified other terms associ-
ated with MAPK14 activity such as “transcription from RNA poly-
merase II promoter” and “positive regulation of transcription from
RNA polymerase II promoter,” including sites Ser320 in FOSL2,
Ser666 in HCFC1, Ser90 and Ser100 in JUND, Ser250 in NFIX,
Ser727 in STAT1, and Ser371 in TP53BP1. The recruitment of
RNA polymerase II complex to regulate transcription requires
MAPK14 activity (Ferreiro et al. 2010); furthermore, this process
has also been related with the chromatin remodeling necessary
for OB differentiation (Villagra et al. 2006).
Besides MAPK14, we identified other kinases possibly in-
volved in the regulation of commitment to osteoblastic lineage.
Several putative sites for AKT protein kinases and their down-
stream targets, RPS6KB1 (ribosomal protein S6 kinase B1) and
RPS6KB2, were observed to be regulated immediately following
OB induction. Conversely, the promiscuous casein kinase 2 alpha
catalytic subunits (CSNK2A1–3) were found to be a possible kinase
for many of the overrepresented but not regulated sites (Fig. 5A).
Figure 3. Commitment to the osteoblast lineage leads to numerous alterations in kinase expression and phosphorylation status. Identified and quantified
kinases were ordered by the phylogenetic distance of their kinase domains and aligned using iTOL. Color codes for distinct kinase families are shown in the
right bottom corner. Histogram in the inner ring represents the regulation at protein level at the corresponding time points, whereas bars on outer ring show
number and direction of regulated phosphorylation sites.
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As a complementary approach, we grouped regulated phos-
phorylation sites into eight clusters using fuzzy c-means (Fig.
5B). Although some phosphorylations were only affected at 24 h
(Cluster 2), most sites underwent changes during earlier time
points and returned close to baseline levels (Clusters 3–8), indicat-
ing temporal and stage-specific effects. We then performed sepa-
rate KEGG pathways and kinase substrate enrichment analyses to
explore for discrete signaling pathways and individual kinases, re-
spectively, with significant overrepresentation within any of the
clusters. We observed enrichment of several receptor tyrosine ki-
nase (RTK) signaling pathways, for example, EGF, VEGFA, and in-
sulin in Clusters 6–8 (Supplemental Table S3). In agreement with
the preceding findings arguing for an involvement of the MAPKs
and the placement of these kinases as nodal points in RTK net-
works, MAPK signaling was also tightly associated with the same
clusters (Supplemental Table S3). Besides MAPK, other signaling
cascades known to be involved in OB differentiation, like MTOR
and FOXO pathways, were enriched in these clusters as well
(Teixeira et al. 2010; Pramojanee et al. 2014; Dai et al. 2017). An
additional set of sites that showed increased phosphorylation at
the onset of differentiation (Cluster 8) were affiliated with another
nodal point kinase family, AKT (Fig. 5B), reflecting the role of
the AKT signaling in the initial phase of OB differentiation.
Collectively, Clusters 6–8 could therefore be assigned to a first
wave of phosphorylation events and appear to be a compilation
of several signaling cascades.
Regarding the pathways associated with the second activa-
tionwave, sites targeted by group II of the PAK (p21 [RAC1] activat-
ed kinase) family of kinases (PAK4, PAK5, and PAK6) were
overrepresented in Cluster 2 containing sites with up-regulation
at 24 h with little or no fluctuations at earlier time points (Fig.
5B). Although this group of kinases has been implicated in several
biological processes and tumor formation, its role inOB biology re-
mains unexplored (Wells and Jones 2010). Of note, proteins in-
volved in Hippo and TGFB signaling were up-regulated at their
protein levels at this latest time point (Supplemental Fig. S1), argu-
ing for an involvement of these signaling pathways in the second
kinase activation wave as well. A pattern therefore emerges, in
which several intertwined kinase-signaling pathways commonly
initiated by RTKs are activated, and their downstream effectors
MAPK and AKT act as the radial points during the first wave. As
these routes cling off, a more defined program is initiated, involv-
ing PAK, TGFΒ, and Hippo signaling networks.
PRKD1 regulates osteoblast differentiation via HDAC7
phosphorylation
From the kinase prediction analyses, serine/threonine protein ki-
nase D1 (PRKD1) showed the highest enrichment with substrates
predominantly found in Clusters 1 and 7 (Fig. 5B). In accordance,
western blotting with phospho-specific antibody revealed that the
activating Ser910 phosphorylation on PRKD1 was indeed aug-
mented 30 min after induction and declined to baseline levels at
the 6- and 24-h time points (Fig. 6A; Supplemental Fig. S4A). We
therefore assessed the involvement of PRKD1 in the commitment
of hMSCs to osteoblastic cells using a PRKD1-specific chemical in-
hibitor, CRT0066101 (Harikumar et al. 2010). The inhibition of
PRKD1 had only a mild effect on the early phosphorylation status
of MAPK14, a canonical target of PRKD1 (Supplemental Fig. S3A).
We also examined the effect of stimulating hMSCs with phorbol
myristate acetate (PMA), which is a potent activator of several
members of the PKC family of kinases, including PRKD1. Despite
the very strong activation of PRKD1 (Fig. 6B; Supplemental Fig.
S4B), the PMA treatment of the cells did not augment the phos-
phorylation of MAPK14 (Supplemental Fig. S3A), further indicat-
ing that MAPK14 is not the main target of PRKD1 in the initial
stages of OB lineage commitment.
It has previously been shown that PRKD1 regulates the cyto-
plasmic-nuclear shuttling of members of the class IIa histone
deacetylases and transcriptional repressors (HDAC4, −5 and −7)
by direct phosphorylation (Dequiedt et al. 2005; Parra et al.
2005; Sinnett-Smith et al. 2014). We therefore hypothesized that
PRKD1 may regulate OB differentiation through phosphorylation
and relocalization of one or more of the HDACs. Temporal profile
of the phosphorylation status of the residue in the three HDACs
(HDAC4-Ser632/HDAC5-Ser661/HDAC7-Ser486) controlling for
their nuclear-cytoplasmic shuttling and targeted by PRKD1, was
virtually identical to the activation pattern of the kinase (Fig. 6A;
Supplemental Fig. S4A). In support of PRKD1 being responsible
for this phosphorylation, CRT0066101 treatment resulted in
decreased HDAC phosphorylation, whereas activation of PRKD1
by PMA increased the phosphorylation of HDACs (Fig. 6B;
Supplemental Fig. S4B). Although the phospho-specific antibody
recognizes all three HDACs when phosphorylated at these posi-
tions, the phosphorylation dynamics of HDAC4 Ser632 and
HDAC5 Ser661 were quantified in the MS analyses and neither
showed significant changes (Supplemental Table S2), indicating
that the PRKD1 effect is mediated mainly through phosphoryla-
tion of HDAC7 Ser486. Because this phosphorylation site is known
to regulate HDAC cellular localization (Parra et al. 2005), we as-
sessed the effect of the PRKD1 inhibitor on the distribution of
HDAC7 in hMSCs. Upon induction of OB differentiation,
HDAC7 was translocated from the nucleus to the cytoplasm in ve-
hicle treated cells. This relocalizationwas completely prevented by
the PRKD1 inhibitor (Fig. 6C; Supplemental Fig. S4C), suggesting
that PRKD1 regulates OB commitment of hMSCs through phos-
phorylation and nuclear exclusion of the RUNX2-repressor
HDAC7. In support, the mRNA levels of four RUNX2 target genes
and early osteoblast gene markers were all significantly decreased
by the PRKD1 inhibitor (Fig. 6D). In addition, siRNA-mediated
Figure 4. Knockdown of regulated kinases alter osteoblast differentia-
tion. Before induction of differentiation, hMSCs were transfected with
siRNAs targeting indicated kinases. Six days postinduction, the degree of
differentiation was scored by measuring alkaline phosphatase (ALPL)
activity, displayed relative to the scrambled siRNA–transfected control
hMSCs: (∗) P<0.05, Student’s t-test. Background coloring is based on
the observed quantitative proteomics changes during differentiation:
(red) decreased protein level; (green) increased protein level; (yellow) al-
tered phosphorylation.
Signaling waves during hMSCs osteoblast commitment
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BA
Figure 5. Motif analyses revealed kinases with likely involvement in osteoblastogenesis. (A) Significantly overrepresented linear phosphorylation motifs
were identified with Motif X and matched to kinases predicted with NetworKIN (Linding et al. 2008), in which an increase in purple intensity equals an
increase in the percentage of the given site that is predicted to be phosphorylatable by the given kinase (left). The identified motifs were hierarchically
clustered according to the average phosphorylation dynamics of the sites matching each motif. The average change in phosphorylation of sites matching
themotif in each time point is color-coded blue for decreased or red for increased compared to undifferentiated cells. Only average phosphorylation chang-
es with amean significantly different from zero on confidence level 0.01 were included. (B) Class I sites were clustered according to their temporal dynamics
(left). Fisher’s exact test with Benjamini–Hochberg adjustment was used to identify kinases with significant overrepresentation of substrates within any of
the clusters (right).
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knockdown of PRKD1 in hMSCs resulted in reduced alkaline
phosphatase activity on day 6 of differentiation (Fig. 6E), further
indicating the functional importance of PRKD1 for the OB
differentiation.
Discussion
Lineage commitment and differentiation of hMSCs into osteo-
blastic cells is a complex cellular process. Our analyses provide a
first global view of the complex proteomic and phosphoproteomic
changes during the initial 24 h of hMSCs transition to the OB lin-
eage. We identified 6252 proteins and 15,059 unique phosphory-
lation sites during the early steps of OB conversion. The data
exposed that osteoblast commitment involves complex makeover
already at the first 24 h, including changes in phosphoproteins as-
sociated with cell proliferation, extracellular matrix, and vascular
remodeling, all known to be important for efficient OB differenti-
ation (Lian and Stein 1995).
By modulating gene expression, transcription factors are re-
sponsible for a large part of the dynamics in the proteome. We
found that the expression of several members of the bZIP family
was increased during OB differentiation, arguing for a strong in-
volvement of these transcription factors in regulating OB commit-
ment. Both CEBPB and CEBPD were up-regulated, and both have
previously been shown to be involved in osteoblastic lineage com-
mitment through cooperative actions with RUNX2 (Gutierrez
et al. 2002; Tominaga et al. 2008). In contrast, another bZIP factor
devoid of a transactivating domain, namely MAFK, was down-
regulated at all time points (Fig. 2). It is possible that MAFK
restricts OB differentiation because it has the ability to bind and
repress other bZIPs and especiallyMAF (Kataoka et al. 1996), which
plays an essential role in OB develop-
ment through interplay with RUNX2
(Nishikawa et al. 2010).Moreover, we ob-
served temporal inhibition of the NF-kB
transcription factors and Rho activity
(Supplemental Fig. S1). These observa-
tions are also in agreement with previous
data showing a strong inhibitory effect
on OB differentiation by the two signal-
ing pathways (Novack 2011; Strzelecka-
Kiliszek et al. 2017).
The dynamics of regulated phos-
phorylation sites and protein expression
changes indicated the existence of two
consecutive signaling waves, the first
peaking immediately after induction
of differentiation followed by a second
commencing 24 h after initiation (Sup-
plemental Fig. S5). During the first
wave, a myriad of signaling cascades are
activated, including a number of RTK
pathways. The exact contribution of each
signaling component awaits further ana-
lyses, but it is likely that their mutual
crosstalk is of pivotal importance for a ba-
lanced and timed initiation of OB differ-
entiation. This is exemplified by the fact
that several of the phosphorylated pro-
teins are embedded in more than one
pathway. RAF1 and TSC2, when phos-
phorylated on Ser29 and Ser1319, respectively, are both key nodes
in interaction betweenMTORandMAPKpathways (Mendoza et al.
2011). Other sites such as Ser2 in RRAGCor Ser226 inMAP2K2 are
known to have the potential to activate each of the pathways inde-
pendently. Both pathways can converge on the same transcription
factors such as FOXO (Mendoza et al. 2011), whose localization is
also affected by STAT3 (Oh et al. 2012), which we find phosphor-
ylated at Ser727 as well (Supplemental Table S2). Collectively, nu-
merous pathways with several shared nodal points are activated at
this first wave during differentiation.
The second wave of signaling appears to rely on a completely
different set of signaling cascades (Supplemental Fig. S5). Of the
lesser studied but highly enriched pathways in our data, the up-
regulation of the Hippo pathway suggests strong involvement of
this cascade 24 h after induction of differentiation (Lee et al.
2015). This concurs with an up-regulation of the expression of
transforming growth factor beta receptor 2 (TGFBR2), arguing for
crosstalk between these two pathways in the OB commitment as
they also cooperate in other biological processes (Luo 2017).
KEGG-based enrichment analysis of phosphorylation sites aug-
mented at this later stage suggested activation of the DNA repair
machinery as well (Supplemental Table S3). The DNA damage re-
sponse was previously associated with differentiation processes
(Sherman et al. 2011), arguing thatmaintaining genomic integrity
is also essential for the progress of OB conversion. In our data we
found XPC, known member of pluripotency-maintaining com-
plex (Cattoglio et al. 2015), to become phosphorylated at Ser883
and Ser884. The LIG1 and LIG3 proteins, reported to be involved
in human neural crest stem cell differentiation (Newman et al.
2017), were phosphorylated at Ser51 and Thr244, respectively, as
well (Supplemental Table S2). Moreover, substrates for the group
II of the PAK kinases were increasingly phosphorylated at the 24 h
EB
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D
Figure 6. PRKD1 regulates HDAC7 localization in immortalized hMSCs. (A) Western blot images of
HDAC and PRKD1 phosphorylation levels during osteoblast differentiation, n=2. (B) Western blot of
HDAC and PRKD1 phosphorylation 30 min and 1 h after induction of osteoblastic differentiation, with
and without PRKD1 inhibitor (PKDi), n=2. (C) Detection of HDAC7 in unstimulated hMSCs (Control),
30 min after osteoblastic induction (30 min OD) with and without PKDi or PMA-treated hMSCs, n=3.
(D) mRNA levels of CTGF, CEBPD, CYR61, and ALPL in relative expression 24 h after osteoblastic differ-
entiation with and without PKDi. (E) Quantitation of alkaline phosphatase (ALPL) activity on day 6 of os-
teoblast differentiation of hMSC transfectedwith control nontargeting siRNA (siCtrl) or two independent
siRNAs targeting PRKD1 (siPRKD1 #1, siPRKD1 #2). For D and E: (∗) P<0.05, Student’s t-test; n=3.
Signaling waves during hMSCs osteoblast commitment
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time point. These kinases are at least partially activated by the
small GTPases, CDC42 and RAC1. CDC42 has been shown to in-
duce chondrogenesis, but not OB differentiation, downstream
from TGFB stimulation through the group I PAK member PAK1
and MAPK14 (Wang et al. 2016). It is therefore conceivable that
the diverging groups of this family of kinases integrates upstream
signaling events and balances osteoblast versus chondrocyte line-
age commitment.
As a follow up on the global changes during OB differentia-
tion, we identified a mechanistic involvement of PRKD1. At first,
two complementary approaches that predict kinases responsible
for the dynamic changes in the phosphoproteome at the onset
of OB differentiation revealed pivotal roles for MAPK14 and
PRKD1 kinases. Members of the MAPK family, and notably
MAPK14, arewell known for their involvement inOB lineage com-
mitment (Rodríguez-Carballo et al. 2016). PRKD1 has also at sever-
al instances been described as a key mediator of the bone
morphogenetic protein (BMP)-induced OB differentiation, mainly
through activation of the MAPK14 (Lemonnier et al. 2004; Celil
and Campbell 2005; Kim et al. 2011). In our study, the addition
of a PRKD1 inhibitor did not affect the level of the activating phos-
phorylation ofMAPK14, suggesting independent effects of the two
kinases within the first hours of OB differentiation. In agreement
with a previous study focused on BMP signaling (Jensen et al.
2009), we observed a PRKD1-dependent nuclear exclusion of the
RUNX2-repressive HDAC7. It is therefore likely that part of the
stimulatory effect of PRKD1 on OB differentiation is mediated
through the relief of RUNX2 from HDAC7-mediated repression.
Our study shows that lineage commitment of hMSCs can be
conceptualized as coordinated successive waves of interacting sig-
naling pathways, where the “choir is more important than the
solo” (Kassem and Bianco 2015). From a translation perspective,
our findings suggest a possibility for a more flexible, multiple pro-
tein targeting approach to better control hMSCs lineage commit-
ment to osteoblastic cells and bone regeneration, an important
application in regenerative medicine.
Methods
Cell culture, SILAC labeling, and differentiation
As amodel for humanprimaryMSCs,we usedhMSC-TERT cell line
that has been immortalized by ectopic expression of telomerase
reverse transcriptase gene (hTERT) (Simonsen et al. 2002). For sim-
plicity, we will refer to the hMSC-TERT as hMSCs throughout
the paper. For SILAC experiments, cells were labeled with L-argi-
nine (Arg0) and L-lysine (Lys0) for the unstimulated cells,
L-arginine-13C6 (Arg6) and L-lysine-
2H4 (Lys4) for the 30-min
and 1-h conditions, or L-arginine-13C6
15N4 (Arg10) and L-ly-
sine-13C6
15N2 (Lys8) for the 6- and 24-h conditions (Cambridge
Isotope Laboratories) at concentrations of 28 and 42mg/L, respec-
tively. Differentiation of hMSCs cells into the osteoblastic lineage
was performed as described previously (Kratchmarova et al. 2005).
For PRKD1 inhibition, CRT0066101 (Abcam) was added 30 min
before the induction of OB differentiation at a final concentration
of 10 µM. For PRKD1 activation, phorbol myristate acetate (PMA)
(Sigma-Aldrich) was used at a final concentration of 150 ng/mL.
Sample processing for LC-MS/MS analysis
Two triple-encoding SILAC experiments were performed in paral-
lel for each replicate (total of three biological replicates). Cells
were stimulated for 30 min, 1 h, 6 h, or 24 h, rinsed twice with
cold PBS and lysed in 50 mM Tris, pH 7.5, 150 mM NaCl, 1%
NP-40, 0.1% sodium deoxycholate, and 1 mM EDTA supplement-
ed with phosphatase and protease inhibitors (Roche). Nuclei
were pelleted by centrifugation for 10 min at 10,000g at 4°C.
Cytoplasmic proteins in the supernatant were precipitated using
acetone and resuspended in 10 mM Tris, pH 7.5, with 6 M urea
and 2 M thiourea. The same buffer, supplemented with Ben-
zonase, was used for resuspension of nuclear proteins. Protein con-
centrations were determined using Bradford (Bio-Rad) according
to the manufacturer’s instructions. Samples were combined in a
1:1:1 ratio (L:M:H). Proteins were reducedwith 10mMdithiothrei-
tol and alkylated with 55 mM iodoacetamide. For protein iden-
tification, 100 µg protein of each SILAC pool were separated
using 1D SDS-polyacrylamide gel electrophoresis on NuPAGE
Novex gels (Life Technologies). The gel was stained with Colloidal
Blue (Life Technologies), cut into pieces, and digested with trypsin
(Promega) overnight at 37°C. Resulting peptide mixture was ex-
tracted and desalted using modified Stage tips as described else-
where (Akimov et al. 2011). The remainder of the protein lysates
was used for phosphopeptide enrichment before MS analysis.
Proteins were digested in solution for 4 h at room temperature
with LysC (Wako Chemicals) followed by trypsin overnight (Aki-
mov et al. 2018), used in a ratio of 1:160 and 1:200, respectively,
relative to protein content. Peptide solutions were acidified with
trifluoroacetic acid to a final concentration of 0.1% and cleared
by centrifugation (20,000g, 5 min). Phosphopeptides were en-
riched and fractionated using TiO2 as described earlier (Rigbolt
et al. 2011a).
LC-MS/MS analysis
Peptides were separated using an in-house packed fused silica col-
umn with a length of 15 cm, an inner diameter of 75 µm and re-
verse phase material (3 µm C18, ReproSil-Pur C18 AQ) (Dr.
Maisch HPLC GmbH, Ammerbuch Germany). EASY-nLC
(Proxeon), Agilent 1100, or Agilent 1200 systems were used, gen-
erating linear gradients of 90 min (solvent A was 0.5% acetic acid
in water, and solvent B was 80% Acetonitrile and 0.5% acetic
acid) at a constant flow of 250 nL/min.Mass spectrometry was per-
formed in positive ion mode using LTQ-Orbitrap XL for total
protein coverage (data-dependent acquisition for isolation and
fragmentation of the 10 most intense ions, CID fragmentation)
and LTQ-Orbitrap Velos and Q-Exactive for phospho-enriched
samples (data-dependent acquisition for isolation and fragmenta-
tion of the 10 most intense ions for Velos and the 12 most intense
for Q-Exactive, HCD fragmentation) (all from Thermo Fisher
Scientific).
Data analysis is described in detail in Supplemental Methods.
Briefly, all MS raw files from the three biological replicas were pro-
cessed together using the MaxQuant with FDR of 1% set for both
protein and site identification. Protein with shared peptides were
combined in protein groups, and both unique and razor peptides
were used for quantitation.
Clustering of protein and sites based on their temporal profiles
Phosphosite SILAC ratios were normalized where possible by di-
viding the phosphosite ratio with total protein ratio to ensure
that changes were caused by the dynamics of the site and not
the protein. Resulting values were log2 transformed and subjected
to unsupervised clustering with the fuzzy c-means algorithm im-
plemented in the GProX software (Rigbolt et al. 2011b). Only sites
with a complete profile, P<0.05 (Significance A, MaxQuant) and a
ratio with at least a twofold increase or decrease in at least one time
point were considered. Enrichment analysis for kinase substrates
within the clusters were performed using Fisher’s exact test with
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Benjamini–Hochberg adjustment for multiple testing (Benjamini
and Hochberg 1995). Protein ratios were subjected to the same
method, designating as changing proteins with P<0.05
(Significance A, MaxQuant) with at least 1.5-fold increase or
decrease in at least one point. Details for additional bioinformatic
analyses are provided in Supplemental Methods.
Immunocytochemistry and western blotting
Immunocytochemistry was performed as previously described
(Sanchez-Quiles et al. 2017). Briefly, cells were fixed with 4% para-
formaldehyde, permeabilized with 0.1% Triton X-100, and
blocked with horse serum. Cells were incubated with mouse
anti-HDAC7 antibody (Santa Cruz Biotechnology sc-74563),
rinsed, incubated with anti-mouse/Cy3 secondary antibody (Jack-
son ImmunoResearch 715-165-150) plus DAPI (Sigma-Aldrich),
and rinsed before mounted on cover slides. Images were acquired
using an Observer Z1 microscope (Zeiss). See Supplemental Meth-
ods for western blotting details.
Quantitative real-time polymerase chain reaction (qRT-PCR)
and siRNA transfections
Relative mRNA levels were measured by qRT-PCR as previously
described (Hallenborg et al. 2016; Supplemental Methods). A
reverse transfection protocol using Lipofectamine 2000
(Invitrogen) was used for the siRNA transfections. hMSC cultures
were trypsinized, and 18,000 cells/cm2 were reverse-transfected
with two independent siRNAs targeting the kinases (Supplemen-
tal Methods) in two biological replicates for each siRNA. For
PRKD1, the experiment was performed in triplicate for each of
its siRNAs.
Quantitation of alkaline phosphatase (ALPL) activity
To quantify alkaline phosphatase activity, p-nitrophenyl phos-
phate (Fluka) was used as substrate and to correct for differences
in cell number, ALPL activity data were normalized to cell viability
measurements as described previously (Jafari et al. 2017). Briefly,
CellTiter-Blue reagent (Promega) was added to the normal culture
medium, incubated for 1 h at 37°C, and fluorescent intensity
(560EX/590EM) was measured using FLUOstar Omegamultimode
microplate reader (BMG Labtech). Cells were then washed with
Tris-buffered saline (TBS), fixed in 3.7% formaldehyde, 90% etha-
nol at room temperature for 30 sec, incubated with substrate
(1 mg/mL of p-nitrophenyl phosphate in 50 mM NaHCO3,
pH 9.6, and 1 mMMgCl2) for 20 min at 37°C, and the absorbance
measured at 405 nm, using FLUOstar Omega multimode micro-
plate reader.
Data access
The mass spectrometric data generated in this study have
been submitted to the ProteomeXchange Consortium (http
://proteomecentral.proteomexchange.org) via the PRIDE partner
repository with the data set identifier PXD011001.
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